MDS Nordion Provides Long-term Cobalt Supply for Sterilisation Industry

Ottawa, Canada (ots/PRNewswire) - MDS Nordion, the world's largest
supplier of medical isotopes, is pleased to announce it has extended
an exclusive agreement with Bruce Power to provide a reliable supply
of cobalt until 2019. This partnership produces over 40% of the
world's supply of cobalt, used primarily for the sterilisation of
medical devices and consumer products.

"We are very pleased that MDS Nordion continues to invest in these
partnerships," said Lin Nai-jie, General Manager of Shenzhen JPY Ion
Tech Co. Ltd. "Growth in our market is significant, and a reliable,
stable supply of cobalt is an important component of positioning this
technology and our company as leaders in sterilisation."

Today approximately 45% of the single use medical devices produced
worldwide are sterilised using gamma sterilisation. These include
disposable medical devices and supplies such as surgeon's gloves,
syringes, sutures and catheters, as well as pharmaceuticals, implants
and tissue. The process, in use for more than 40 years, has been
proven safe, reliable, and highly effective for sterilisation, as
well as disinfestation of fruits and vegetables to meet international
quarantine regulations, the treatment of cosmetic products, and to
enhance the material properties of polymers.

"We are committed to providing an integrated solution for our
customers in the sterilisation industry," said Steve West, President,
MDS Nordion. "Our solution encompasses securing long-term strategic
partnerships, complemented by a full breadth of advanced
sterilisation technology and services."

"We're pleased to play our part in helping meet the increased
demand for sterilisation solutions," said Duncan Hawthorne, Bruce
Power's President and Chief Executive Officer. "That demand means
increased supply requirements, which provides new opportunities for
power generators like us."

About Bruce Power

Bruce Power generates more than 4,700 MW of electricity from its
six reactor units and is a partnership among Cameco Corporation,
TransCanada Corporation, BPC Generation Infrastructure Trust, a trust
established by the Ontario Municipal Employees Retirement System, the
Power Workers' Union and The Society of Energy Professionals.

About MDS Nordion

MDS Nordion (www.mds.nordion.com) is a world leader in
radioisotopes, radiation and related technologies. MDS Nordion is
part of MDS Inc. (TSX: MDS; NYSE: MDZ). MDS Inc. is a global life
sciences company that provides market- leading products and services
that our customers need for the development of drugs and diagnosis
and treatment of disease. We are a leading global provider of
pharmaceutical contract research, medical isotopes for molecular
imaging, radiotherapeutics, and analytical instruments. MDS has more
than 8,800 highly skilled people in 28 countries. Find out more at
www.mdsinc.com or by calling +1-888-MDS-7222, 24 hours a day.

ots Originaltext: MDS Nordion; MDS Inc.
Im Internet recherchierbar: http://www.presseportal.de

Contact:
Shelley Maclean, External Communications, MDS Nordion, Tel:
+1-613-592-3400 ext. 2414, E-mail: shelley.maclean@mdsinc.com